UK-China company will officially unveil new IP trading office and the CNUK Fund to support innovative UK companies
CNUK Medtech Solutions – the UK and Chinese healthcare industry specialist – will host an international summit on innovative medical technology exchange in Nanjing on 26 June 2019.
The summit takes place during Nanjing Tech Week: a high-profile event supported by the Nanjing Municipal Government – and attended by Chinese Prime Minister Mr Li Ke Qiang and Singaporean Prime Minister Mr Le Hsien Loong – for innovators to exchange groundbreaking ideas and showcase cutting-edge technologies.
CNUK Medtech Solutions is a China-UK joint venture specialising in facilitating and accelerating the introduction of medical technology from the UK to China. Its team of UK and Chinese healthcare industry specialists has extensive experience in product development and marketing in both countries, and in bringing new products from the West to the Chinese system.
CNUK has been invited to attend Nanjing Tech Week as guests of the Nanjing Municipal Government and will host the ‘International Summit on Innovative Medical Technology Exchange’ from its new intellectual property trading office and demonstration space on Wednesday 26 June.
Guests invited to join the Summit include members of the Department for International Trade of the British Consul General in Shanghai and representatives from the Jiangsu (provincial), Nanjing (municipal) and Xuanwu (district) governments.
Representatives from UK companies in the healthcare industry – including medical innovators ClearSky Medical Diagnostics, RD Biomed, Veraz, Tranquality and Aelius Biotech – will introduce and showcase their advanced technologies and innovations to representatives from the healthcare and pharmaceutical industries, investment firms, local distributors and Chinese universities.
The official CNUK office opening event will feature speeches on UK-China cooperation by James Maguire, Assistant Director at the UK Department for International Trade Shanghai, and the partnership opportunities to commercialise novel NHS medtech solutions by Professor Michael Smith of the UK healthcare innovation hub, Medipex.
CNUK will also introduce its new CNUK Fund delivering managed investment opportunities to develop UK early stage innovative med tech products and support their commercialisation in China.
At an evening cocktail event, CNUK will also co-host the 'Challenges and Opportunities for AI and Healthcare in China' discussion panel with Nanjing Healthcare Drinks, the UK Department of Trade and MyBioGate.
Mark Atherton, Head of Business Development at CNUK Medtech Solutions, says: “We’re looking forward to welcoming innovators, government officials, industry partners and potential investors to the official launch of the CNUK Medtech Solutions new office space during the prestigious Nanjing Tech Week. This is an excellent opportunity for us to introduce our vision, growth strategy and latest developments in the medical technology industry, including the introduction of our new investment Fund, while giving UK innovators the platform to showcase their technology and services.”
About CNUK Medtech Solutions
CNUK is a team of UK and Chinese healthcare industry specialists with a passion for improving the management and delivery of medical services through the adoption of innovative Med-Tech products and services. With more than 35 years' experience in the health care industry and an extensive network of investors across China, CNUK Medtech Solutions has supported UK medical technology companies to progress in China, including ClearSky Medical Diagnostics, Veraz, Zilico and Cipher Surgical. For more information, visit www.cnukmed.com or www.linkedin.com/company/cnuk-medtech-solutions-limited. Imagery is available.
Contact: Mark Atherton, Head of Business Development on firstname.lastname@example.org or
+44 (0) 113 328 1140.
Press release distributed by Pressat on behalf of CNUK Medtech Solutions, on Friday 21 June, 2019. For more information subscribe and follow http://www.pressat.co.uk/